Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)
Agency: National Institutes of Health
Assistance Listings: 93.866 -- Aging Research
Description
The National Institute on Aging (NIA) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research on Alzheimer's disease (AD) and AD-related dementias (ADRD) drug target validation and early-stage drug discovery against novel targets. This NOFO will utilize the U01 activity code. The NOFO will support rigorous preclinical AD/ADRD drug target validation and early-stage drug discovery of small molecules, biologic, and emerging therapeutic modalities. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. Investigators with expertise and insights into AD/ADRD and drug discovery are encouraged to begin to consider applying for this new NOFO.
Eligibility
Eligible applicants
Miscellaneous
- Other
Business
- Small businesses
- For-profit organizations other than small businesses
Education
- Public and state institutions of higher education
- Private institutions of higher education
- Independent school districts
Nonprofit
- Nonprofits non-higher education without 501(c)(3)
- Nonprofits non-higher education with 501(c)(3)
- Other Native American tribal organizations
Government
- Special district governments
- Federally recognized Native American tribal governments
- County governments
- City or township governments
- Public and Indian housing authorities
- State governments
Additional information
Grantor contact information
Description
NIA-NOFO-Scientific@nih.gov
Documents
No documents are currently available.
Link to additional information
--
Forecasted
Estimated Post Date:
July 31, 2026
Estimated Application Due Date:
October 5, 2026
Estimated Due Date Description:
Not available
Estimated Award Date:
July 1, 2027
Estimated Project Start Date:
July 1, 2027
Fiscal Year:
2027
Award
$--
Program Funding
--
Expected awards
$--
Award Minimum
$--
Award Maximum
Funding opportunity number:
PAR-26-132
Cost sharing or matching requirement:
Funding instrument type:
Cooperative agreement
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Health
Category Explanation:
History
Version:
1
Forecast posted date:
March 4, 2026
Archive date:
--
